Results 171 to 180 of about 184,554 (278)

Case‐Based Immunology: B Cells and Systemic Sclerosis Interstitial Lung Disease

open access: yesArthritis &Rheumatology, EarlyView.
Interstitial lung disease (ILD) is an important complication of systemic sclerosis (SSc), with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to US Food and Drug Administration–approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of ILDs of other systemic autoimmune
Nina Goldman   +2 more
wiley   +1 more source

Domino heart transplant following heart-lung transplantation: a systematic review and meta-analysis. [PDF]

open access: yesAnn Cardiothorac Surg, 2020
Maynes EJ   +9 more
europepmc   +1 more source

Heart, Lung and Heart–Lung Transplantation

open access: yes, 2017
Patricia Muñoz   +2 more
openaire   +1 more source

Telomere Length of Peripheral Blood Leukocytes Predicts Disease Severity and Worse Survival in Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Objective Peripheral blood leukocyte telomere length (PBL‐TL) shortening is associated with systemic sclerosis–related interstitial lung disease (SSc‐ILD). However, its association with other organ involvement, disease severity, and survival remains unclear.
Monica M. Yang   +6 more
wiley   +1 more source

Four decades of heart-lung transplantation: Milestones and outcomes in advanced cardiorespiratory failure. [PDF]

open access: yesESC Heart Fail
Rosenthal LL   +10 more
europepmc   +1 more source

Linezolid prevents fibroblast activation and ameliorates tissue fibrosis by inhibition of mitochondrial translation

open access: yesArthritis &Rheumatology, Accepted Article.
Background Beyond its role as a ribosome‐targeting antibiotic, linezolid was recently shown to modulate immune responses by inhibiting mitochondrial translation. Since mitochondrial dysfunction is implicated in various fibrotic diseases, including systemic sclerosis (SSc), this study aimed to evaluate the antifibrotic potential of linezolid and ...
Xuezhi Hong   +13 more
wiley   +1 more source

Renal Outcomes After Lung or Combined Heart-Lung Transplantation in Pulmonary Hypertension. [PDF]

open access: yesPulm Circ
Hardy L   +17 more
europepmc   +1 more source

Recent improvement in clinical pancreas transplantation [PDF]

open access: yes, 1987
Abendroth, D.   +4 more
core   +1 more source

Heart, lung and heart–lung transplantation

open access: yes, 2010
Patricia Muñoz   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy